Osteoarthritis, KneeNCT05128864
High Tibial Osteotomy With/Without Fulkerson Osteotomy in Knee OA
A study testing High Tibial Osteotomy in people with Osteoarthritis, Knee and Patellofemoral Disorder, run by Centre of Postgraduate Medical Education at 1 site in Poland.
Trial summary
This study will compare Hight Tibial Osteotomy with or without Fulkerson Osteotomy performed on patients with early stages of Osteoarthritis with patellofemoral joint disorders. The purpose of this study is evaluate which type of osteotomy provides better clinical, radiological and laboratory outcomes. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Osteoarthritis, Knee, Patellofemoral Disorder
- What is being tested?
- High Tibial Osteotomy
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 110 participants
- Where
- 1 sitePoland
- Study dates
- 15 Jul 2020to 30 May 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Knee medial compartment or patellofemoral osteoarthritis in medical interview and physical examination
- Confirmation of cartilage degeneration/damage and knee malalignment in radiological tests
Who cannot join
- no informed consent to participate in the study
- age under 18 years or above 65
- multi ligament injury or single plane knee instability
- another musculoskeletal disorders in lower limb
- lower limb deformity requiring axis correction below 4o or above 12.5o
- joints inflammatory diseases
- ASA score > II
Trial locations and contacts
1 site in 1 country.
Poland1 site, 1 recruiting
- Recruiting
Department of Orthopaedics and Traumatology, Postgraduate Center for Medical Education, Professor A. Gruca Teaching Hospital
Otwock, Masovian Voivodeship, 05-400
Rafal Kaminski, MD PhD, +48227794031 ext. 431, rkaminski@spskgruca.pl
Stanislaw Pomianowski, MD PhD Prof, +48227794031 ext. 481, spom@spskgruca.pl
About this study
Official title: Prospective, Randomized, Double Blinded Trial Comparing Clinical, Radiological and Laboratory Outcomes of Hight Tibial Osteotomy With or Without Concomitant Fulkerson Osteotomy
This study will compare Hight Tibial Osteotomy with or without Fulkerson Osteotomy performed on patients with early stages of Osteoarthritis with patellofemoral joint disorders. The purpose of this study is evaluate which type of osteotomy provides better clinical, radiological and laboratory outcomes.
Read the detailed description
Progression of knee cartilage degenerative changes leads to necessary total knee arthroplasty in future, which is the most popular procedure for treating OA. HTO applied at early stages of osteoarthritis allow slow down cartilage degeneration process, but the choice of performed surgery depends on surgeons personal assessment. Patellofemoral Pain Syndrome often occurs with knee arthritis. Antero-medialisation of tibial tubercle is frequent procedures for patella maltracking. So far, both, HTO and Fulkerson osteotomy was performed separately, even if patient have symptoms from patellofemoral joint and OA. The investigators believe that simultaneously surgery of HTO and fulkerson Osteotomy provides better outcomes and significantly slow down knee degeneration.
- Conditions
- Osteoarthritis, Knee, Patellofemoral Disorder
- Being tested
- High Tibial Osteotomy
- Keywords
- HTO, Fulkerson, Osteoarthritis
- Medical subject headings
- Osteoarthritis, Knee, Osteoarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
High Tibial OsteotomyProcedure or surgery
Surgery procedure - High Tibial Osteotomy
| Study group | Role | What they receive |
|---|---|---|
| HTO and Fulkerson | Active comparator | High Tibial Osteotomy with Antero-medialisation of Tibial Tubercle Receives: Procedure: High Tibial Osteotomy |
| HTO | Sham comparator | Descending Hight Tibial Osteotomy Receives: Procedure: High Tibial Osteotomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Biomechanics MRI
Patellofemoral Joints Biomechanics improvement measured
Measured: 1 year
Biomechanics MRI
Patellofemoral Joints Biomechanics improvement measured
Measured: 2 years
Biomechanics X-ray
Patellofemoral Joints Biomechanics improvement measured
Measured: 12 weeks
Biomechanics X-ray
Patellofemoral Joints Biomechanics improvement measured
Measured: 6 months
Biomechanics X-ray
Patellofemoral Joints Biomechanics improvement measured
Measured: 12 months
Biomechanics X-ray
Patellofemoral Joints Biomechanics improvement measured
Measured: 24 months
Secondary outcomes (22)
KOOS
Knee Injury and Osteoarthritis Outcome Score
Measured: 12 weeks
KOOS
Knee Injury and Osteoarthritis Outcome Score
Measured: 6 months
KOOS
Knee Injury and Osteoarthritis Outcome Score
Measured: 12 months
KOOS
Knee Injury and Osteoarthritis Outcome Score
Measured: 24 months
IKDC
International Knee Documentation Committee
Measured: 12 weeks
IKDC
International Knee Documentation Committee
Measured: 6 months
IKDC
International Knee Documentation Committee
Measured: 12 months,
IKDC
International Knee Documentation Committee
Measured: 24 months
Tegner Lysholm
Tegner Lysholm Knee Scoring Scale
Measured: 12 weeks,
Tegner Lysholm
Tegner Lysholm Knee Scoring Scale
Measured: 6 months
Tegner Lysholm
Tegner Lysholm Knee Scoring Scale
Measured: 12 months
Tegner Lysholm
Tegner Lysholm Knee Scoring Scale
Measured: 24 months
SF-36
The Short Form (36) Health Survey
Measured: 12 weeks
SF-36
The Short Form (36) Health Survey
Measured: 6 months
SF-36
The Short Form (36) Health Survey
Measured: 12 months
SF-36
The Short Form (36) Health Survey
Measured: 24 months
VAS
Pain Visual Analog Scale
Measured: 12 week
VAS
Pain Visual Analog Scale
Measured: 6 months
VAS
Pain Visual Analog Scale
Measured: 12 months
VAS
Pain Visual Analog Scale
Measured: 24 months
Blood test
CRP, IL-6, CTx
Measured: 2nd day
Blood test
CRP, IL-6, CTx
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Nov 2021
- Study start15 Jul 2020
- Primary completion30 May 2022 (estimated)
- Study completion30 May 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Osteoarthritis, KneeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Outcomes assessor
- Enrolment
- 110 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre of Postgraduate Medical Education
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rafał Kamiński, Centre of Postgraduate Medical Education
- Investigators
- Rafal Kaminski, Principal investigator, PCME, Otwock, Poland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05128864
- Sponsor's protocol ID
- HTO_fulkerson
- Status last verified
- Nov 2021
- First submitted
- 18 Jul 2020
- Last updated
- 22 Nov 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Nov 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prospective, Randomized, Double Blinded Trial Comparing Clinical, Radiological and Laboratory Outcomes of Hight Tibial Osteotomy With or Without Concomitant Fulkerson Osteotomy
- ClinicalTrials.gov ID
- NCT05128864
- Acronym / sponsor ID
- HTO_fulkerson
- Conditions
- Osteoarthritis, Knee, Patellofemoral Disorder
- Keywords
- HTO, Fulkerson, Osteoarthritis
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 110 participants (estimated)
- Lead sponsor
- Centre of Postgraduate Medical EducationUniversity, hospital or other
- Study start
- 15 Jul 2020 (actual)
- Primary completion
- 30 May 2022 (estimated)
- Study completion
- 30 May 2022 (estimated)
- First posted
- 22 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will compare Hight Tibial Osteotomy with or without Fulkerson Osteotomy performed on patients with early stages of Osteoarthritis with patellofemoral joint disorders. The purpose of this study is evaluate which type of osteotomy provides better clinical, radiological and laboratory outcomes.
Detailed description
Progression of knee cartilage degenerative changes leads to necessary total knee arthroplasty in future, which is the most popular procedure for treating OA. HTO applied at early stages of osteoarthritis allow slow down cartilage degeneration process, but the choice of performed surgery depends on surgeons personal assessment. Patellofemoral Pain Syndrome often occurs with knee arthritis. Antero-medialisation of tibial tubercle is frequent procedures for patella maltracking. So far, both, HTO and Fulkerson osteotomy was performed separately, even if patient have symptoms from patellofemoral joint and OA. The investigators believe that simultaneously surgery of HTO and fulkerson Osteotomy provides better outcomes and significantly slow down knee degeneration.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, care provider, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| HTO and Fulkerson | Active comparator | Procedure: High Tibial OsteotomyHigh Tibial Osteotomy with Antero-medialisation of Tibial Tubercle |
| HTO | Sham comparator | Procedure: High Tibial OsteotomyDescending Hight Tibial Osteotomy |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Knee medial compartment or patellofemoral osteoarthritis in medical interview and physical examination
- Confirmation of cartilage degeneration/damage and knee malalignment in radiological tests
Key exclusion criteria (7 listed)
- no informed consent to participate in the study
- age under 18 years or above 65
- multi ligament injury or single plane knee instability
- another musculoskeletal disorders in lower limb
- lower limb deformity requiring axis correction below 4o or above 12.5o
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| High Tibial OsteotomySurgery procedure - High Tibial Osteotomy | Procedure or surgery | HTO, HTO and Fulkerson |
Primary outcome
Biomechanics MRI
Time frame: 1 year
Patellofemoral Joints Biomechanics improvement measured
Biomechanics MRI
Time frame: 2 years
Patellofemoral Joints Biomechanics improvement measured
Biomechanics X-ray
Time frame: 12 weeks
Patellofemoral Joints Biomechanics improvement measured
Biomechanics X-ray
Time frame: 6 months
Patellofemoral Joints Biomechanics improvement measured
Biomechanics X-ray
Time frame: 12 months
Patellofemoral Joints Biomechanics improvement measured
Biomechanics X-ray
Time frame: 24 months
Patellofemoral Joints Biomechanics improvement measured
22 secondary outcomes
KOOS
Time frame: 12 weeks
KOOS
Time frame: 6 months
KOOS
Time frame: 12 months
KOOS
Time frame: 24 months
IKDC
Time frame: 12 weeks
IKDC
Time frame: 6 months
IKDC
Time frame: 12 months,
IKDC
Time frame: 24 months
Tegner Lysholm
Time frame: 12 weeks,
Tegner Lysholm
Time frame: 6 months
Tegner Lysholm
Time frame: 12 months
Tegner Lysholm
Time frame: 24 months
SF-36
Time frame: 12 weeks
SF-36
Time frame: 6 months
SF-36
Time frame: 12 months
SF-36
Time frame: 24 months
VAS
Time frame: 12 week
VAS
Time frame: 6 months
VAS
Time frame: 12 months
VAS
Time frame: 24 months
Blood test
Time frame: 2nd day
Blood test
Time frame: 6 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Nov 2021.
Related trials for Osteoarthritis, Knee
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
RecruitingObservational study
Exploring Factors Linked to Worsening Over Time in People With Early-stage Knee Osteoarthritis and Those With Prior Proven Acute Knee Injury.
Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rafal Kaminski principal investigator
PCME, Otwock, Poland
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing High Tibial Osteotomy in people with Osteoarthritis, Knee and Patellofemoral Disorder, run by Centre of Postgraduate Medical Education at 1 site in Poland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Rafał Kamiński, MD PhD (+48227794031 ext. 469, kaminski@spskgruca.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Biomechanics MRI (time frame: 1 year). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Nov 2021.